The Supreme Court has agreed to hear a case on the abortion pill mifepristone, the most widely used method of abortion in the U.S. In August, the 5th Circuit Court sided with a right-wing Texas judge who argued the FDA improperly eased regulations on the pill to make it more accessible, and that it should only be used up to seven weeks into a pregnancy and only issued in person. The Biden administration said the ruling “threatens to undermine the FDA’s scientific independent judgment and would reimpose outdated restrictions on access to safe and effective abortion medication.” For now, mifepristone remains available through telemedicine, mail delivery and via pharmacies — pending the Supreme Court’s decision, which is expected by the end of June next year.